NVCT
NVCT
NASDAQ · Biotechnology

Nuvectis Pharma Inc

$8.89
+0.48 (+5.71%)
As of Feb 8, 2:04 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 66.09M 69.56M 73.83M
Net Income 7.65M 9.76M 11.38M
EPS
Profit Margin 11.6% 14.0% 15.4%
Rev Growth +12.3% +24.1% -0.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 97.76M 88.37M 98.46M
Total Equity 128.28M 136.69M 131.71M
D/E Ratio 0.76 0.65 0.75
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 12.79M 14.57M 15.15M
Free Cash Flow 6.98M 8.54M 10.02M